BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9721045)

  • 1. Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice.
    Andoh T; Kuraishi Y
    Eur J Pharmacol; 1998 Jul; 353(1):93-6. PubMed ID: 9721045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12(S)-HPETE induces itch-associated scratchings in mice.
    Kim DK; Kim HJ; Sung KS; Kim H; Cho SA; Kim KM; Lee CH; Kim JJ
    Eur J Pharmacol; 2007 Jan; 554(1):30-3. PubMed ID: 17112507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice.
    Andoh T; Katsube N; Maruyama M; Kuraishi Y
    J Invest Dermatol; 2001 Dec; 117(6):1621-6. PubMed ID: 11886531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal nociceptin elicits itch-associated responses through leukotriene B(4) in mice.
    Andoh T; Yageta Y; Takeshima H; Kuraishi Y
    J Invest Dermatol; 2004 Jul; 123(1):196-201. PubMed ID: 15191560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of azelastine on substance P-induced itch-associated response in mice.
    Andoh T; Kuraishi Y
    Eur J Pharmacol; 2002 Feb; 436(3):235-9. PubMed ID: 11858803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice.
    Andoh T; Kuraishi Y
    Eur J Pharmacol; 2006 Oct; 547(1-3):59-64. PubMed ID: 16914135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice.
    Andoh T; Kuraishi Y
    Eur J Pharmacol; 2000 Oct; 406(1):149-52. PubMed ID: 11011046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects.
    Black PN; Fuller RW; Taylor GW; Barnes PJ; Dollery CT
    Thorax; 1989 Jun; 44(6):491-5. PubMed ID: 2548300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions.
    Andoh T; Haza S; Saito A; Kuraishi Y
    Exp Dermatol; 2011 Nov; 20(11):894-8. PubMed ID: 21824199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B₄-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1.
    Fernandes ES; Vong CT; Quek S; Cheong J; Awal S; Gentry C; Aubdool AA; Liang L; Bodkin JV; Bevan S; Heads R; Brain SD
    FASEB J; 2013 Apr; 27(4):1664-73. PubMed ID: 23271050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin.
    Andoh T; Saito A; Kuraishi Y
    J Invest Dermatol; 2009 Dec; 129(12):2854-60. PubMed ID: 19657356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Leukotriene B4 Released from Keratinocytes in Itch-associated Response to Intradermal Interleukin-31 in Mice.
    Andoh T; Harada A; Kuraishi Y
    Acta Derm Venereol; 2017 Aug; 97(8):922-927. PubMed ID: 28512667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of leukotriene B4 in 5-lipoxygenase metabolite- and allergy-induced itch-associated responses in mice.
    Tsuji F; Aono H; Tsuboi T; Murakami T; Enomoto H; Mizutani K; Inagaki N
    Biol Pharm Bull; 2010; 33(6):1050-3. PubMed ID: 20522976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of 5-lipoxygenase metabolite in itch-associated response of mosquito allergy in mice.
    Kuraishi Y; Ohtsuka E; Nakano T; Kawai S; Andoh T; Nojima H; Kamimura K
    J Pharmacol Sci; 2007 Sep; 105(1):41-7. PubMed ID: 17827870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β2-Microglobulin, interleukin-31, and arachidonic acid metabolites (leukotriene B
    Li S; Andoh T; Zhang Q; Uta D; Kuraishi Y
    Eur J Pharmacol; 2019 Mar; 847():19-25. PubMed ID: 30659825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of pranlukast and leukotriene B4 receptor antagonist on antigen-induced pulmonary reaction.
    Sakurada T; Abe M; Kodani M; Sakata N; Katsuragi T
    Eur J Pharmacol; 1999 Apr; 370(2):153-9. PubMed ID: 10323264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of leukotriene B(4) and prostaglandin E(2) release from keratinocytes by protease-activated receptor-2-activating peptide in ICR mice.
    Zhu Y; Wang XR; Peng C; Xu JG; Liu YX; Wu L; Zhu QG; Liu JY; Li FQ; Pan YH; You BM; Hu JH
    Int Immunopharmacol; 2009 Oct; 9(11):1332-6. PubMed ID: 19712758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide enhances substance P-induced itch-associated responses in mice.
    Andoh T; Kuraishi Y
    Br J Pharmacol; 2003 Jan; 138(1):202-8. PubMed ID: 12522091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of leukotriene B4 in dermatophyte-related itch in mice.
    Andoh T; Takayama Y; Kuraishi Y
    Pharmacol Rep; 2014 Aug; 66(4):699-703. PubMed ID: 24948074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP.
    Andoh T; Kuraishi Y
    J Dermatol Sci; 2014 Dec; 76(3):206-13. PubMed ID: 25458869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.